Getz Family Professor of Cancer, Professor of Medicine, Mayo Medical School Distinguished Mayo Investigator

Hematology

Dr. Rafael Fonseca is an expert in the field of Hematology. He attended Universidad Anahuac School of Medicine. Rafael Fonseca is also a published MD. He has 36 paper published. The most recent paper is: Extramedullary Cardiac Multiple Myeloma-A Case Report and Contemporary Review of the Literature. Rafael Fonseca accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Tumor associated macrophages (TAMs) and extraczellular matrix metalloproteinase inducer (EMMPRIN) in prognosis of multiple Myeloma.
• Longitudinal Analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).
• Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before Disease progression.
• Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic Leukemia.
• Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia.
• Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single agent activity in patients with relapsed multiple Myeloma.
• Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk Disease.
• Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple Myeloma.
• Identification of cereblon binding proteins and relationship with response and survival following pomalidomide and dexamethasone in multiple Myeloma.
• Predicting multiple myeloma disease activity by Analyzing natural calcium isotopic composition.
• IMWG consensus on risk stratification in multiple Myeloma.
• Staging and prognostication of multiple Myeloma.
• Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma.
• Mass spectrometry-based proteomics reveals that leukocyte Cell-derived chemotaxin 2 associated amyloidosis is a frequent cause of hepatic amyloidosis in the United Sta...
• Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-Cell origin.
• The clinical significance of cereblon expression in multiple Myeloma.
• Myeloma: classification and risk assessment.
• Smoldering multiple Myeloma requiring treatment: time for a new definition?
• Non-secretory Myeloma: clinical and biologic implications.
• Management of newly diagnosed symptomatic multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.
• Impact of Primary Molecular Cytogenetic Abnormalities and Risk of Progression in Smoldering Multiple Myeloma.
• CGH Protocols: Chronic Lymphocytic Leukemia.
• DNA methylation in multiple Myeloma is weakly associated with gene transcription.
• Plasma cell Leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
• Whole genome sequencing of multiple myeloma from diagnosis to plasma cell Leukemia reveals genomic initiating events, evolution and clonal tides.
• Clonal competition with alternating dominance in multiple Myeloma.
• Impact of risk stratification on outcome among patients with multiple Myeloma receiving initial therapy with lenalidomide and dexamethasone.
• Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple Myeloma: high response rates in a phase II clinical trial.
• Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
• Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple Myeloma patients.
• Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem Cell transpla...
• Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements.
• Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin Lymphoma.
• Lessons from next-generation sequencing Analysis in hematological malignancies.
• Extramedullary Cardiac Multiple Myeloma-A Case Report and Contemporary Review of the Literature.

Schools

---

• Universidad Anahuac Escuela De Medicina

• Jackson Meml Hospital University Miami

• Mayo Clinic Rochester

Procedures Preformed

---

• Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
• HPC Transplantation (Stem Cell Transplant)
• Plasmapheresis

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Education

---

• Mayo School of Graduate Medical Education
• Jackson Memorial Hospital - Jackson Health System
• Universidad Anahuac School of Medicine

Hospital

---

• Mayo Clinic - Phoenix/Scottsdale, Arizona

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Irwin L. Levey, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew J. Buresh, MD This Doctor is OpenDoctor Recommended.
	Dr. Jose F. Leis, MD This Doctor is OpenDoctor Recommended.
	Dr. Thai H. Ho, MD This Doctor is OpenDoctor Recommended.
	Dr. Adrienne D. Briggs, MD This Doctor is OpenDoctor Recommended.
	Dr. Nina J. Karlin, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel D. Von Hoff, MD
	Dr. Donald W. Northfelt, MD This Doctor is OpenDoctor Recommended.
	Dr. Tom R. Fitch, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. James L. Slack, MD
	Dr. Harshita R. Paripati, MD This Doctor is OpenDoctor Recommended.
	Dr. John K. Camoriano, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Joseph R. Mikhael, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Samuel Ejadi, MD This Doctor is OpenDoctor Recommended.
	Dr. Alexander K. Stewart, MD This Doctor is OpenDoctor Recommended.
	Dr. Chad C. Cherington, MD This Doctor is OpenDoctor Recommended.
	Dr. Bruce A. Lenes, MD This Doctor is OpenDoctor Recommended.
	Dr. Renata M. Hanzlik, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog